Featured Research

from universities, journals, and other organizations

Venom From Chilean Tarantula May Prevent Potentially Deadly Arrythmias, University At Buffalo Research Shows

Date:
January 23, 2001
Source:
University At Buffalo
Summary:
A specific protein isolated from the venom of a Chilean tarantula by University at Buffalo biophysicists shows promise as the basis for new drugs for preventing atrial fibrillation, the chaotic beating of the heart that is a major cause of death following a heart attack.

BUFFALO, N.Y. -- A specific protein isolated from the venom of a Chilean tarantula by University at Buffalo biophysicists shows promise as the basis for new drugs for preventing atrial fibrillation, the chaotic beating of the heart that is a major cause of death following a heart attack.

Related Articles


In a study published this month in Nature, Frederick Sachs, Ph.D., UB professor of physiology and biophysics, along with researchers from Georgetown University, report they were able to prevent atrial fibrillation in rabbit hearts by an infusion of a peptide isolated from tarantula venom.

This is the first time that the physiological function of mechanosensitive ion channels has been demonstrated in the heart.

The work is an example of how basic research can lead to clinical payoffs, Sachs stated. "No one in their right mind would have sought to block atrial fibrillation with spider spit," he said. "We did it backwards. Since we had found venom worked on single molecules, we predicted it would also work on cells, tissues and organs. And it did.

"This is a first step toward developing a new class of drugs that may be applied to cardiac pathology and to the pathology of other organs," Sachs said. "Despite the fact that all cells have mechanical sensitivity, there are no other pharmacological agents specific to biological mechanical transducers."

Sachs and postdoctoral researcher Tom Suchyna, Ph.D., at UB's Center for Single Molecule Biophysics, along with colleagues at the University of Virginia, Michigan State and NPS Pharmaceuticals, Inc., reported isolating the protein last May. At that time, they suggested that it might have many uses, based on its ability to block pores in cell membranes called stretch-activated channels. These channels, which derive their name from the fact that stretching the cell membrane causes them to open, are responsible for regulating the mechanical functioning of cells -- a cellular sense of touch. Sachs and colleagues discovered these channels at UB in 1983 in skeletal muscle cells.

Stretch-activated channels have been implicated in functions as diverse as the senses of touch and hearing, blood pressure and volume regulation and coordination of the voluntary musculature, as well as the contraction of heart muscle. Composed of 10 billion excitable muscle cells, the heart cells must contract in synchrony in order to pump blood effectively. When heart tissue becomes stretched through disease, such as congestive heart failure, trouble ensues.

The chambers of the heart expand, stretching cells. Furthermore, as a result of poor blood perfusion, cells swell, stimulating stretch-activated channels to open and allowing an influx of positive ions. This influx is an excitatory stimulus to the heart that disrupts the electrical balance, causing the cells to fire erratically. The tarantula-derived peptide, known as GSMtx-4, blocks this process.

The next phase of Sachs' research involves producing large amounts of the peptide by recombinant DNA technology and chemical synthesis, studying the mechanism of action, identifying other potential biological actions on stretch-activated channels and collaborating with a drug company in turning GsMtx-4 into a clinically useful drug.

The research was funded by grants from the National Institutes of Health, U.S. Army Research Office and NPS Pharmaceuticals, Inc.


Story Source:

The above story is based on materials provided by University At Buffalo. Note: Materials may be edited for content and length.


Cite This Page:

University At Buffalo. "Venom From Chilean Tarantula May Prevent Potentially Deadly Arrythmias, University At Buffalo Research Shows." ScienceDaily. ScienceDaily, 23 January 2001. <www.sciencedaily.com/releases/2001/01/010122075758.htm>.
University At Buffalo. (2001, January 23). Venom From Chilean Tarantula May Prevent Potentially Deadly Arrythmias, University At Buffalo Research Shows. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2001/01/010122075758.htm
University At Buffalo. "Venom From Chilean Tarantula May Prevent Potentially Deadly Arrythmias, University At Buffalo Research Shows." ScienceDaily. www.sciencedaily.com/releases/2001/01/010122075758.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins